demand and delivery events with corresponding 
timestamps are extracted from the PCA logs. The time 
series of D/D ratio will be pre-processed through the 
aggregation technique of sliding window. A four-hour 
and twelve-hour windows are adopted to calculate the 
D/D ratio and the window slides every one hour. 
Patients who adopted genitourinary surgery and 
patient-controlled analgesia therapy were selected in 
this study. To obtain a reasonable PCA clinical 
effectiveness index, we design a fuzzy logic 
algorithm for quantifying clinical effectiveness. The 
establishment of fuzzy control rules was cooperated 
with the anesthesiologists. The results have 
demonstrated that the generated PCA clinical 
effectiveness index gives a reliable and suitable 
estimation of the PCA service. It fulfills the 
requirement of therapy evaluation. 
英文關鍵詞： patient-controlled analgesia, decision support 
system, clinical effectiveness index 
 
 2 
醫師大多考量其體重與年齡開立處
方，在療程中可能因不同療效反應而
進行調整。 
3. Lockout interval (min)：鎖定時間，短
時間用藥安全防護機制，於每次
Delivery 執行時觸發，此期間內
Demand將判定為無法給藥，確保止痛
藥開始作用前病人不會再次獲得
Bolus dose，在療程中可能因不同療效
反應而進行調整。 
4. Four hour limit (ml)：四小時限制，長
時間累積用藥量限制，控制器啟動後
每四小時計算一次，此為週期內病人
可獲得的最大藥劑總量，Loading 
dose、Bolus does與 Infusion rate的劑
量皆包含在內。 
5. Infusion rate (ml/hr)：輸注速率，持續
性的流速型注射以維持病人體內的藥
劑濃度，由麻醉醫師評估病情後開
立，在療程中可能因不同療效反應而
進行調整。 
   透過病患自控式止痛服務進行疼痛治
療已行之有年[12, 13]，雖可配合個體主觀感
受擁有自我調控的給藥能力，但並非所有
病人均對止痛療效感到滿意，據台北榮民
總醫院統計訪視所登記的止痛效果，如圖 1
所示，仍有 16%的病人覺得完全無效，推
究其主要原因可能為：所設定的給藥模式
與實際需求有落差，以致於病人在療程期
間無法得到預期的舒緩效果，尤其病患自
控式止痛療程為自費項目，病人更加重視
其醫療品質，進而造成醫療滿意度下降；
國人對於嗎啡類止痛藥物使用上的觀念偏
差，以及傳統教育中普遍認為忍耐是一種
美德，造成國人使用病患自控式止痛服務
時，往往痛到無法承受時才按下手握式按
鈕，不敢依其主觀感受使用自控止痛，無
法有效維持體內的有效止痛濃度，導致醫
療服務品質下降。 
 
圖 2 台北榮民總醫院病患自控式止痛效果 
二、研究目的 
在病患自控式止痛服務療程中，通常
以 Demand與 Delivery的比值 D/D ratio代
表疼痛控制的效果，數值趨近於 1 代表良
好的疼痛控制，然而卻有病人發生副作用
的可能性存在，如何在止痛與副作用之間
取得平衡，仍是非常值得探討的研究議
題，尤其是副作用仍有致命的潛在危機
時，更應該要詳細分析出高危險因子，適
時給予麻醉醫師開立醫囑時的重要參考依
據。本計畫欲利用資料探勘技術與模糊理
論，建立病患自控式止痛服務疼痛管理決
策系統，包含決策系統、給藥標準以及療
效指標。 
1. 給藥標準：利用現有病患自控式止痛
資料庫，包含病人基本生理特徵、手
術相關資訊、用藥醫囑、血液檢驗值、
每日訪視資料、問題回報記錄以及微
電腦記錄等，研究副作用好發族群與
所對應的預防藥劑量，並探討肝腎功
能檢驗值以及長期慢性病與止痛用藥
之間的關係，提出藥劑調整建議量與
參數，最後將已開發的最優化給藥模
式加以歸納為基本用藥劑型，進行適
當的整合歸納後提出多元化考量的病
患自控式止痛給藥標準。 
2. 決策系統：當給藥標準建立後需要決
策程序判斷病人所屬的給藥標準型
別，故利用資料探勘技術將病人歸納
至最符合其生理需求的給藥標準，輸
入參數為療程進行前可得的病人資
料，包含基本生理特徵、手術相關資
料、血液檢驗數值以及長期慢性病
史，經過分群、分類與整合的運算後，
可決定病人的最優化用藥設定與預防
藥劑量，提供麻醉科醫師開立醫囑時
的給藥參考標準。 
3. 療效指標：疼痛是主觀意識難以客觀
的量化與評估，目前病患自控式止痛
療效評估方式以護理人員訪視為主，
須主動詢問病人的疼痛指數與副作用
等級，卻無法以科學方法測得其強度
與特性造成客觀性不足，而一日僅兩
 4 
性的 3.01倍，故女性病人在接受止痛
服務時，可以考慮預先加入止吐藥降
低副作用發生率。 
4. 療效評估：病患自控式止痛控制器的
微電腦記錄資訊，包含用藥設定以及
病人在療程間所有 Demand 與
Delivery 事件，適時地加以分析能提
供病人真實的用藥反應[23, 24]，微電腦
記錄經由剖析程序後，可計算單位時
間內的 D/D ratio。為降低變因與觀察
純粹由病人進行自控止痛的資料特
徵，分析對象只採用 IVPCA 且
Infusion rate固定為每小時 0.1~0.2 ml
共 97筆個案，結果發現資料特性主要
呈現五種類型：Flat、Descending、
Middle-High、Ascending 與 M-Peak 
profile，以不同的療程特徵作為輸入
資料，利用模糊理論建立病患自控式
止痛療效評估系統，結果以 Best、
Good、Normal、Bad與Worst呈現療
效，參考護理人員於訪視時所登記的
醫療滿意度為 85%，而療效評估系統
的結果為 79%，故在適當的發展後可
為病患自控式止痛療效參考依據。 
四、研究方法 
  本計畫利用資料探勘技術發展病患自
控式止痛服務疼痛管理決策系統，包含開
發決策系統、建立給藥標準與設計療效指
標。資料探勘常用技術包括迴歸分析、類
神經網路、決策樹、基因演算法、規則推
論法以及模糊理論，其中迴歸分析經常被
運用於決策制定的統計分析方法，研究一
個應變數與一個或多個因變數之間的關
係，並找出一個適當的數學關係式可用來
表達兩者之間的統計關係，適合用在分析
大量樣本資料，對數學關係式區分出不同
影響程度的變數，並可用以預測及因果分
析；模糊理論為建立數學模型解決真實世
界中普遍存在的模糊現象，提供處理人類
邏輯思維的推論過程，設計智慧型系統以
解析描述性的語言，解決許多傳統集合或
理論無法描述的現象與問題，病患自控式
止痛日常訪視記錄為病人主觀回答的重要
資料，然而卻充滿著語意模糊，故本研究
採用模糊理論進行決策系統與療效指標的
設計開發。 
  進行病患自控式止痛給藥標準設定，
在已開發完成的最優化模式中加入更符合
病人需求的考量因素，提供詳細的給藥設
定與藥物種類建議。另外，利用模糊理論
發展決策系統與療效指標，進行病患自控
式止痛服務前，在決策系統中輸入病人相
關參數以決定止痛給藥標準建議，療程結
束後利用微電腦記錄與病人回報資料執行
療效指標評估，以了解病人是否有得到預
期的止痛效果。 
1. 給藥標準：醫院中不同科別的手術特
性差異甚大，而各科別的手術部位與
傷口大小可進行歸納整理，故最優化
給藥設定模式首先進行科別的分群，
利用止痛用藥量相關因子可分為不同
給藥族群，例如不同性別與體重範
圍，並可預測療程前 48小時所需用藥
量，據統計病患自控式止痛若有設定
Infusion rate，則大約有 30%的累計用
藥量來自 Bolus dose，經由計算可得
合理的給藥設定範圍，包含 Loading 
dose、Bolus dose、 Infusion rate、
Lockout interval與 4-hour limit等；另
外在先前的研究分析中證實療程期間
所需止痛用藥量隨時間增加而下降，
故將提供調整用藥設定的參考時間，
以符合人體復原所需止痛用藥劑量，
降低通報護理站要求調整用藥的發生
率。在開始病患自控式止痛療程前，
麻醉護理人員須登記病人與腎臟相關
的 BUN和 CREAT檢驗值，以及與肝
臟相關的 ALT 與 AST 檢驗值，這四
種檢驗值做為病人代謝能力的參考依
據，麻醉醫師須根據數值進行給藥調
整；現行止痛劑型表中特別註明腎臟
衰竭的 IVPCA病人，須降低 infusion 
rate或是只給 bolus dose，然而卻沒有
給予明確的調整數據資料，利用資料
倉儲進行相關統計分析，將可提供明
確的調整依據，並納入病患自控式止
痛給藥標準分析中。
 6 
算每一個時間框架，若設定時間框
架大小為 4 小時則將產生 45 個
D/D4 ratio序列，如圖 3所示，D/Di 
ratio為模糊系統輸入參數的基礎。 
 
圖 3 D/D4 ratio滑動視窗 
 
圖 4 12小時滑動視窗與參數 ithD/D12×i 
(2) 療效評估系統：模糊控制系統包含
模糊化、模糊規則庫、模糊推論機
制以及解模糊程序。在模糊化輸入
參數中，第一項參數利用 45 個
D/D4 ratio，將後項減去前項取得
ΔD/D4( 4 1 4 4/ / /th i ii D D i D D i D D+∆ = − )
，藉以了解短時間內 D/D ratio的
前後變化。第二項模糊化輸入參數
採用 37個 D/D12 ratio，增加滑動
視窗時間框架以了解病人長時間
的疼痛控制特徵，將 D/D12 ratio
與其時間序列的乘積總和作為第
二項模糊化輸入參數，如圖 4 所
示，其數學式如下所列，其中 i為
時間框架序號。 
37
12
1
/th
i
i D D i
=
×∑  
    ΔD/D4 模糊化參數採用三角
形歸屬函數，而 ithD/D12×i之總和
歸屬函數採用梯形；模糊規則庫則
採用「IF-THEN」的邏輯形式表
述，將所有可能發生結果列出後由
麻醉科醫師根據經驗法則制訂，透
過規則敘述療效指標系統的可能
發生狀態與結果；在模糊推論機制
中採用 min-min-max推論法，模糊
語意輸入後觸發多條符合條件之
規則，進一步進行模糊推論機制的
運算；最後解模糊化方式為重心解
模糊化法，將推論結果的模糊集合
轉化成明確集合，進行實際的控制
動作或結果分析，提供五項病患自
控式止痛療效等級。 
五、結果與討論 
  本計畫採用回溯式資料分析，對象為
台北榮民總醫院 2005年 4月 18日至 2010
年 4月 29日接受病患自控式止痛服務的泌
尿外科病人，因計畫執行期間適逢醫院更
換病患自控式止痛裝置服務廠商，在考量
新裝置銜接期問題以及資料庫所收集的個
案數量後，本計畫微電腦記錄分析的病患
自控式止痛裝置型號為 Abbott AIM Plus，
在刪除使用未滿四十八小時、微電腦記錄
出現亂碼及少數使用特殊藥物的個案後，
最後共 312樣本納入分析。 
  泌尿外科病患自控式止痛給藥標準如
表 1 所示，透過多元線性回歸分析可得前
48小時病人用藥預測，藉由臨床經驗比例
分配計算出最佳給藥設定建議，最後將給
藥標準納入病患自控式止痛決策系統，如
 8 
 
圖 7 模糊化輸入參數 ithD/D12×i之總和歸屬函數 
  兩項模糊輸入參數可組合出 162 條規
則，經由專業麻醉醫師依據其臨床經驗篩
選後保留 32 條規則，如表 2 所示。透過
min-min-max 模糊推論機制後可得五項模
糊療效指標，分別為 positive+、positive、
normal、negative以及 negative-，代表模糊
療效指標，歸屬函數如圖 8所示。 
表 2 病患自控式止痛療效指標模糊規則庫 
 IF THEN 
No 
37
1
12/
i
thi D D i
=
∑ ×  
ΔD/D4 
Output 
Decrease Zero Increase 
1 Level-1 Middle Big Small Positive 
2 Level-1 Middle Middle Middle Normal 
3 Level-1 Small Big Small Positive+ 
4 Level-2 Middle Middle Middle Normal 
5 Level-2 Middle Big Middle Normal 
6 Level-2 Middle Big Small Positive 
7 Level-2 Middle Middle Small Positive 
8 Level-2 Small Big Middle Normal 
9 Level-2 Small Big Small Positive 
10 Level-3 Big Small Big Negative 
11 Level-3 Big Small Middle Normal 
12 Level-3 Middle Middle Big Normal 
13 Level-3 Middle Middle Middle Normal 
14 Level-3 Middle Big Middle Normal 
15 Level-3 Middle Big Small Normal 
16 Level-3 Middle Small Big Negative 
17 Level-3 Small Big Middle Negative 
18 Level-3 Small Big Small Normal 
19 Level-4 Middle Middle Middle Negative 
20 Level-4 Big Middle Middle Negative 
21 Level-4 Big Middle Small Negative 
22 Level-4 Middle Big Middle Negative 
23 Level-5 Middle Big Middle Negative 
24 Level-5 Middle Middle Middle Negative 
25 Level-5 Big Middle Small Negative 
26 Level-5 Big Small Big Negative 
27 Level-5 Middle Middle Small Negative 
28 Level-5 Middle Small Big Negative 
29 Level-5 Small Big Small Normal 
30 Level-6 Middle Small Big Negative- 
31 Level-6 Middle Middle Middle Negative- 
32 Level-6 Middle Small Middle Negative- 
 
圖 8 模糊療效指標歸屬函數 
  最後將模糊療效指標解模糊後可得五
項明確語意等級的病患自控式止痛療效指
標，分別為 Best、Good、 Normal、Bad以
及Worst，統計結果如圖 9所示，其中 Best
佔 18%、Good佔 23%、 Normal佔 37%、
Bad佔 17%以及Worst佔 5%，將代表正常
以上的 Best、Good 和 Normal 加總後為
78%，此結果利用病患自控式止痛每日巡
房所登記的止痛效果進行驗證，其普通有
效、有效和非常有效的總和為 84%，與本
計畫所開發的療效指標結果近似。 
 
圖 9 病患自控式止痛療效指標統計 
  本計畫利用資料探勘技術發展病患自
控式止痛服務疼痛管理決策系統，研究成
果可預測泌尿外科病患自控式止痛給藥標
準，藉由臨床經驗比例分配計算出最佳給
藥設定建議後，加上肝腎功能的血液檢驗
值納入病患自控式止痛給藥決策系統，提
供麻醉醫師更詳盡的給藥設定參考，並在
療程結束後提供療效指標，回饋病人對於
當次療程的止痛滿意度，藉此提升病患自
控式止痛服務醫療品質。 
 1 
 
國科會補助專題研究計畫項下出席國際學術會議心得報告 
                                     日期：101年 1月 20日 
                                 
一、參加會議經過 
  本次會議為 IEEE- Engineering in Medicine and Biology Society (EMBS)所舉
辦的特殊主題-生物醫學與健康資訊國際研討會(International Conference on 
Biomedical and Health Informatics, BHI)，連結第八屆醫療設備與生物感測器國際
會議(International Symposium on Medical Devices and Biosensors)以及第七屆生
物醫學與健康工程國際會議(International Symposium on Biomedical and Health 
Engineering)，會議整體焦點為世界健康資訊的重要挑戰(Global Grand Challenge 
of Health Informatics)，提供獨特的論壇給生物醫學與健康資訊的最優化輸出、
傳輸、處理、儲存與檢索，醫療設備與系統與臨床研究報告配合，提出在健康
資訊系統與建置遠距醫療遠距醫療的創新應用。與會專家來自中國、美國、土
耳其、義大利、英國、臺灣、荷蘭、日本、德國以及加拿大等 21個國家，分享
並提供有關醫療資訊發展的心得與建議，議程包含 22場邀請演講、16場口頭報
告以及 4場論文壁報展示，接受發表主題包含 P-STAR of Health Information、
計畫編號 NSC 100－2221－E－010－001－ 
計畫名稱 病患自控式止痛服務疼痛管理決策系統之設計 
出國人員
姓名 郭怡婷 
服務機構
及職稱 
國立陽明大學/兼任研究助理 
會議時間 101年 1月 5日至 101年 1月 7日 會議地點 
中國-香港、深圳 
會議名稱 
IEEE-EMBS生物醫學與健康資訊國際研討會 
IEEE-EMBS International Conference on Biomedical and Health 
Informatics 
發表論文
題目 
以行動網際網路設備為基礎電子資料收集系統與調適性給藥模式改善
病患自控式止痛服務 
MID-based Electronic Data Collection and Adaptive Drug Delivery Model 
for Improving Quality of PCA Services 
附件四 
IEEE-EMBS International Conference
on Biomedical and Health Informatics (BHI 2012)
Theme: "Global Grand Challenge of Health Informatics"
Date: 2-7 Jan 2012, Venue: The Chinese University of Hong Kong, Hong Kong, and The V Hotel of Wongtee, Shenzhen, China
Letter of Acceptance
22 November 2011
Mr. Chih-Yen Chiang
Institute of Biomedical Enginnering
National Yang-Ming University
Taiwan
g39504021@ym.edu.tw
Dear Mr. Chih-Yen Chiang,
Congratulations! We are glad to inform you that your submission:
"MID-based Electronic Data Collection and Adaptive Drug Delivery Model for Improving Quality of PCA Services", (Paper ID:
20316)
has been accepted for presentation at the IEEE-EMBS International Conference on Biomedical and Health Informatics (BHI2012).
A Pre-conference Workshop will be held at The Chinese University of Hong Kong, Hong Kong SAR, on January 2-5, 2012, and the
main conference will be held at The V Hotel of Wongtee, Shenzhen, on January 5-7, 2012.
Details concerning the schedule of your presentation will be made available shortly and sent to you by e-mail.  Updates will be
posted periodically on the conference website at: http://bhi2012.embs.org.
To view the comments from the reviewers, please login to the conference website and go to "My Submission". We would like to
remind you that authors of ALL accepted papers at BHI2012 must upload the final versions according to the instructions provided
on the conference website. Even if no changes have been recommended by the reviewers, authors MUST UPLOAD a final version
of the paper, fill in the copyright according the publication policy of IEEE and complete online registration by 30 Nov. 2011.
	
With submissions from more than 30 countries and regions and a large number of distinguished invited speakers, BHI2012 promises
to be an exciting event to start off 2012.
We look forward to welcoming you in Hong Kong and Shenzhen!
Sincerely,
Paolo Bonato, Ph.D.
BHI'12 Programme Chair
Carmen C.Y. Poon, Ph.D.
BHI'12 Programme Co-Chair
c.c.
Dr. Yuan-Ting Zhang, BHI'12 Conference Chair
Dr. Morteza Naghavi, BHI'12 Conference Co-chair
Conference Website: http://bhi2012.embs.org/
II. MATERIAL AND METHODS 
A. EDC System Design 
In this study, we adopt the Microsoft Windows Server 2008 
and Microsoft SQL Server 2008 to establish the server 
platform and database server. Database server stored the 
patient data, PCA logs, daily visitation records, events log and 
so forth. The web application is developed as a set of active 
server pages (ASP) using Microsoft Visual Basic .NET 2008, 
which running on Microsoft Internet Information Server 7 (lIS 
7). PCA nurses involved in this study were all allotted a 
mobile internet device (MID) that equipped appropriate touch 
screen panel, adequate data processing speed, and acceptable 
weight. PCA device is Abbott AIM Plus and it supports the 
electronic data collection and post operation PCA log. Any 
RS232 uploading device with online capability can be used to 
upload information to the database server. 
The design of a successful PCA service website involves a 
clearly communicated stepwise process that specifies the 
development of each PCA EDC module [17]. The 
pre-evaluation using a paper prototype is an important design 
phase. Since the prototypes' problems could be cautiously and 
recurrently modified before expensive programming time has 
been invested. The program coding based on the detailed 
programming specifications is imperative. In web-based PCA 
EDC system, the client software resides on the every MID that 
held by each PCA nurse. The system provides friendly 
interface that allows a user to browse the web and access to the 
PCA database. The data security is assured on three levels, 
server level with fuewall, data transmission level with secure 
socket layer (SSL) and application level with 
authentication/authorization of users. Information within the 
web database server includes configurations of drug delivery 
system by anesthesiologist's prescription, daily visitation by 
PCA nurses and events log chart. All the above information 
will aid the anesthesiologists in better understanding 
postoperative PCA results. 
The stepwise design and development process on each PCA 
EDC module is shown as follows. (1) Setting targets and 
requ irements: The main target is to set up of a web-based PCA 
EDC system to improve current data collection system. The 
development team should work on feasibility assessment and 
human resource management. (2) Initial template setting and 
testing: After the initial applications and the corresponding 
work flow are set up, the system designer and manager should 
do a virtual trial run on all procedures and therein apply all 
updates from the trial run. Our system users are the PCA 
nurses and anesthesiologists and they are allotted with various 
interface which fit their designation i.e. PCA nurses need a 
smooth data storage interface and anesthesiologists need the 
most updated patient information and online statistical 
analysis platform. (3) Application's function design: The 
whole content and contexts within the system and initial 
sample/prototype's applications and the workflow chart are all 
listed and checked. The PCA EDC system functions are 
589 
mainly used the PCA nurses during the daily visitation. Since 
the patient requested PCA therapy, a new personal folder in 
the database server is created. PCA nurses use the MID that 
connected to wireless local area network (WLAN) to access 
the database server or event log website while doing daily 
visitation at the patient's sickbed side. Anesthesiologists can 
also access the database server for patient data including PCA 
usage history, daily visitation records and feedback data, and 
the system supplies them with simple online statistical 
calculations. (4) User interface design and testing: The design 
of interface is based on daily visitation paper forms, and a 
virtual system is created for the PCA nurse to use as a pilot 
testing. This is aimed to lower the PCA nurse's learning time 
that will be able to accelerate the progress for system 
implementation. (5) Program coding and testing: When the 
iterative communications between PCA nurses and system 
engineers are completed, the core applications and the user 
interface will be programmed to construct the website. The 
PCA website will be tested and authorized to ensure the 
stability of the system's function. Reinforcement of the data 
layout in virtual forms and prevention in the uploading of 
irrelevant information will be carried out to improve data 
reliability. Users will again assess the reliability of core 
applications and their feedback will be used to fmalize the 
usability of the system. (6) Deployment and online testing: 
Upon finalizing the core applications, online gathering of data 
will take place and users can upload real time data into the 
server via any internet access platforms. 
B. PCA Dosage Information Generator (PCA DIG) 
PCA dosage information generator extracted the detail 
dosage information from the microcomputer log of the PCA 
device, including Loading Dose, Bolus Dose, Infusion Rate, 
and the count of Demand and Delivery [11, 18]. Through the 
data mining process of the PCA DIG, the patient anesthetic 
condition will be generated as referable medication. 
Anesthesiologists could make use of the patient anesthetic 
information to optimize dosage consumption. It leads to make 
lower adverse effects, enhance patient safety, promote 
patients' satisfaction, and upgrade overall medical quality. 
The PCA dosage information generator consists of three 
activities: lexical analysis, analgesic event parsing, and 
dosage information extraction. These activities are performed 
by the modules within the generator termed the lexical 
analyzer, analgesic event parser, and dosage information 
extractor, respectively. The lexical analyzer extracts useful 
text messages from PCA logs that including the events of 
start/stop infusion, initial setting and reconfiguration, demand 
and delivery, and so on. After the lexical analyzing process, 
the analgesic event parser handles the event timestamp to 
match the infusion rate. The extracted information includes 
demand/delivery counts, dosage setting variations and the 
changing time. While calculating the total drug consumption, 
the event timestamp must be clearly identified. The extraction 
commonly fallen between 48 and 72 hours, we divided the 
fIrst 48-hour into 4 time frames and named TF, (0-12), TFII 
(12-24), TFm (24-36) and TF1V (36-48), respectively. All the 
calculated results, including consumption, demand, delivery, 
and infusion rate, will be analyzed and compared by the four 
time frames respectively. 
In this part of study, we adopted the recall type data 
analysis that compiled historical records for statistical 
evidence. The historical records were retrieved from the 
inpatients of the VGH-TPE who were treated with PCA 
therapy, and the records were from April 2005 to April 2010. 
The patient records were divided into two datasets according 
to the two common types of PCA therapy, and they are 
patient-controlled epidural analgesia (PCEA) and intravenous 
patient-controlled analgesia (IVPCA). And of course, the 
patients of different types of PCA therapy were treated by 
different analgesia drugs and different dosages. The patients 
in orthopedics (denoted as ORTHO) are the most common 
subjects that accepted the PCA therapy due to the surgeries in 
this division were often more serious and larger area of 
wounds. After filtering out the special cases and the 
therapeutic duration less than 48 hours, the records in 
ORTHO are 2989 cases in IVPCA and 1943 cases in PCEA. 
The statistical results of PC A dosage information are shown 
in TABLE II. It is obviously that the total analgesic 
consumption and requirement decreased gradually from TF, to 
TF1V• This is because the self-recovery of human body 
affected gradually with time increased and therefore the 
analgesia requirement decreased. The statistics shown in the 
demand and the delivery of TABLE II reveals that the 
patient's demand and delivery tends to increase from TFIIl to 
TF1V either IVPCA or PCEA patients. The causes found were 
that most post-operative patients of orthopedics were arranged 
to start getting off the bed and having simple rehabilitation 
programs in the second day after surgery. Due to the wounds 
may be pulled during the rehabilitation, the induced pain lead 
to higher demand for pain relief. This is the reason why the 
demand counts increased in TF1V. The collected electronic 
data is mined using multiple regression analysis. The 
parameters include total drug consumption in each time frame, 
the level classifIed of pain relief profile, and the settings of 
PCA device. The analysis in ORTHO is known that the total 
drug consumption of the IVPCA patients are high correlated 
with TFb TFn, age, BMI, weight, and sex (p< 0.05). As for the 
PCEA patients, the total drug consumption is related with age, 
weight, and the days of PCA therapy (p< 0.05). The dosage 
information for IVPCA and PCEA generated by the proposed 
adaptive drug delivery model are listed in TABLE III. The 
generated information of dosage consumption combined the 
correlated parameters (weight, BMI, age, etc.) and the time 
parameters (Day1 and Day2). Since the analgesia demand 
changes with time, and dosage differs depending on 
individual's characteristics. Therefore, the proposed adaptive 
drug delivery model optimized the traditional PCA analgesia 
manner according to the related individual characteristics and 
591 
time factors. By calculating the consumption, the patient's 
analgesia dosage can be predicted during the overall PCA 
therapy course. Through adaptive dosage adjustment, the 
PCA therapy becomes a fItter mode for the individual needs 
on post-operative pain relief. 
TABLE II 
STATISTICAL RESULTS OF PCA DOSAGE INFORMATION FOR ORTHOPEDICS 
Consumption 
(ml) 
Demand 
(times) 
Delivery 
(times) 
TF IVPCA PCEA 
17.01 ± 7.92 55.31 ± 18.73 
II 12.18 ± 7.71 54.47 ± 20.53 
III 9.64 ± 6.22 47.72 ± 18.77 
IV 9.72±6.38 48.22 ± 19.00 
25.93 ± 36.64 19.36 ± 30.66 
II 12.51 ± 17.23 15.31 ± 22.06 
III 8.66 ± 13.07 10.46± 17.21 
IV 9.61 ± 14.10 11.75 ± 18.15 
I 8.25 ± 5.53 6.02± 4.94 
II 6.84± 6.02 6.21 ± 5.47 
III 5.03 ± 5.09 4.27 ± 4.39 
IV 5.42 ± 5.60 4.59± 4.34 
Initial 0.62 ± 0.33 3.63 ± 0.92 
Infusion rate 
I 0.59 ± 0.32 3.51 ± 1.01 
II 0.53 ± 0.31 3.38±1.11 (mllhr) 
III 0.47 ± 0.30 3.19 ± 1.15 
IV 0.46 ± 0.29 3.16± 1.16 
TABLE III 
ADAPTIVE DRUG DELIVERY MODEL FOR ORTHOPEDICS PCA 
IVPCA Consumption(TF) 
= 5.511 + 7.2491+ 2.466JJ - 0.104Age - 0.006BM1+ 0.171 Weight - 0.545F 
PCEA Consumption(TF) 
= 32.300 + 6.815 Day! + 6.135 DaY2 - 0.546Age + 0.340 Weight 
TF, : 1 � 1, 11 � 0; TF" : 1 � 0, 11 � 1 ; TFIII : 1 � 0, 11 � 0; TFIV: 1 � 0, 11 � ° 
TFHj : Day, � 1, DaY2 � 0; TFIII_IV Day, � 0, Day, � 1 
Male: F� 0; Female: F� 1 
IV. CONCLUSIONS 
Pain is one direct reflection of physiological function. 
There is no scientifIc method to quantify the degree of pain 
due to the pain is too objective and individually diverse. It is 
why the daily visitation so important for the patients as to trace 
the pain relief condition during the therapy. The daily 
visitation data and events log play important roles in PCA pain 
management qualities. In order to improve the traditional 
inconveniences of PCA data collection system, the proposed 
web-based PCA EDC system was implemented and 
co-worked with the department of anesthesiology (VGH-TPE) 
PCA team. The system design follows the software creation 
process strictly and uses its web-based attributes to improve 
the drawbacks of non-web-based system. This will ultimately 
benefit patients in terms of efficiency and medical service 
standards. Information from patient feedback can be more 
regularly updated and timely improvements can be made. 
Web-based PCA EDC system still has some drawbacks. When 
the internet access failure, users should be able to have offline 
backup mechanism and re-upload function to the database 
國科會補助計畫衍生研發成果推廣資料表
日期:2012/10/29
國科會補助計畫
計畫名稱: 病患自控式止痛服務疼痛管理決策系統之設計
計畫主持人: 詹家泰
計畫編號: 100-2221-E-010-001- 學門領域: 醫學資訊
無研發成果推廣資料
其他成果 
(無法以量化表達之成
果如辦理學術活動、獲
得獎項、重要國際合
作、研究成果國際影響
力及其他協助產業技
術發展之具體效益事
項等，請以文字敘述填
列。) 
無 
 成果項目 量化 名稱或內容性質簡述 
測驗工具(含質性與量性) 0  
課程/模組 0  
電腦及網路系統或工具 0  
教材 0  
舉辦之活動/競賽 0  
研討會/工作坊 0  
電子報、網站 0  
科 
教 
處 
計 
畫 
加 
填 
項 
目 計畫成果推廣之參與（閱聽）人數 0  
 
